AKT1 and neuroblastoma: As shown in Figure 7A and 7B, PDGF-BB treatment caused a robust activation (more than 8 fold) of Akt as determined by pAkt/Akt levels in human neuroblastoma cells and this effect lasted for at least 60 minutes.